Is PAHC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PAHC. It does not provide personalized investment advice.

PAHC (Phibro Animal Health Corporation Class A) Stock Analysis - Financials

Phibro Animal Health Corporation Class A (PAHC) is a publicly traded Healthcare sector company. As of July 28, 2026, PAHC trades at $36.44 with a market cap of $1.38B and a P/E ratio of 15.05. PAHC moved +3.89% today. Year to date, PAHC is -5.67%; over the trailing twelve months it is +20.77%. Its 52-week range spans $16.16 to $60.08. Analyst consensus is neutral with an average price target of $41.00. Rallies surfaces PAHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are PAHC's key financials?

PAHC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PAHC recently traded at $36.44. Market cap is $1.38B. P/E ratio is 15.05. Revenue is $1.50B.

PAHC Key Metrics

Key financial metrics for PAHC
Metric	Value
Price	$36.44
Market Cap	$1.38B
P/E Ratio	15.05
EPS	$2.34
Dividend Yield	0.12%
52-Week High	$60.08
52-Week Low	$16.16
Volume	264.09K
Avg Volume	0
Revenue (TTM)	$1.50B
Net Income	$95.23M
Gross Margin	32.54%

PAHC Analyst Consensus

3 analysts cover PAHC: 0 strong buy, 1 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $41.00.

Common questions about PAHC

What are PAHC's key financials?: PAHC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PAHC recently traded at $36.44. Market cap is $1.38B. P/E ratio is 15.05. Revenue is $1.50B.
Is PAHC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PAHC. It does not provide personalized investment advice.